|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dekker E, Tanis P, Vleugels J, Kasi P and
Wallace M: Colorectal cancer. Lancet. 394:1467–1480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weerasinghe P and Buja LM: Oncosis: An
important non-apoptotic mode of cell death. Exp Mol Pathol.
93:302–308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Trump BF and Berezesky IK:
Calcium-mediated cell injury and cell death. FASEB J. 9:219–228.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peters AA, Jamaludin SYN, Yapa KTDS,
Chalmers S, Wiegmans AP, Lim HF, Milevskiy MJG, Azimi I, Davis FM,
Northwood KS, et al: Oncosis and apoptosis induction by activation
of an overexpressed ion channel in breast cancer cells. Oncogene.
36:6490–6500. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mills EM, Xu D, Fergusson MM, Combs CA, Xu
Y and Finkel T: Regulation of cellular oncosis by uncoupling
protein 2. J Biol Chem. 277:27385–27392. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Majno G and Joris I: Apoptosis, oncosis,
and necrosis. An overview of cell death. Am J Pathol. 146:3–15.
1995.PubMed/NCBI
|
|
9
|
Wang L, Mai Z, Zhao M, Wang B, Yu S, Wang
X and Chen T: Aspirin induces oncosis in tumor cells. Apoptosis.
24:758–772. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guan R, Chen Y, Zeng L, Rees TW, Jin C,
Huang J, Chen ZS, Ji L and Chao H: Oncosis-inducing cyclometalated
iridium(iii) complexes. Chem Sci. 9:5183–5190. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Derrien T, Johnson R, Bussotti G, Tanzer
A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG,
et al: The GENCODE v7 catalog of human long noncoding RNAs:
Analysis of their gene structure, evolution, and expression. Genome
Res. 22:1775–1789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Okugawa Y, Toiyama Y, Hur K, Toden S,
Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR and
Goel A: Metastasis-associated long non-coding RNA drives gastric
cancer development and promotes peritoneal metastasis.
Carcinogenesis. 35:2731–2739. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schmitt AM and Chang HY: Gene regulation:
Long RNAs wire up cancer growth. Nature. 500:536–537. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schmidt LH, Spieker T, Koschmieder S,
Schäffers S, Humberg J, Jungen D, Bulk E, Hascher A, Wittmer D,
Marra A, et al: The long noncoding MALAT-1 RNA indicates a poor
prognosis in non-small cell lung cancer and induces migration and
tumor growth. J Thorac Oncol. 6:1984–1992. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao
SD, Zhang Y, Yang L, Shan W, He Q, et al: Comprehensive genomic
characterization of long non-coding RNAs across human cancers.
Cancer Cell. 28:529–540. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Matsumura H, Shimizu Y, Ohsawa Y, Kawahara
A, Uchiyama Y and Nagata S: Necrotic death pathway in Fas receptor
signaling. J Cell Biol. 151:1247–1256. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Holler N, Zaru R, Micheau O, Thome M,
Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B and Tschopp
J: Fas triggers an alternative, caspase-8-independent cell death
pathway using the kinase RIP as effector molecule. Nat Immunol.
1:489–495. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tanabe K, Nakanishi H, Maeda H, Nishioku
T, Hashimoto K, Liou SY, Akamine A and Yamamoto K: A predominant
apoptotic death pathway of neuronal PC12 cells induced by activated
microglia is displaced by a non-apoptotic death pathway following
blockage of caspase-3-dependent cascade. J Biol Chem.
274:15725–15731. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Akimoto M, Hayashi JI, Nakae S, Saito H
and Takenaga K: Interleukin-33 enhances programmed oncosis of
ST2L-positive low-metastatic cells in the tumour microenvironment
of lung cancer. Cell Death Dis. 7:e20572016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen YG, Satpathy AT and Chang HY: Gene
regulation in the immune system by long noncoding RNAs. Nat
Immunol. 18:962–972. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y, Jiang T, Zhou W, Li J, Li X, Wang Q,
Jin X, Yin J, Chen L, Zhang Y, et al: Pan-cancer characterization
of immune-related lncRNAs identifies potential oncogenic
biomarkers. Nat Commun. 11:10002020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fang T, Liang T, Wang Y, Wu H, Liu S, Xie
L, Zhang Z, Liang J, Yao C, Tan Y and Wang C: An early-onset
advanced rectal cancer patient with increased KRAS gene copy number
showed A primary resistance to cetuximab in combination with
chemotherapy: A case report. Front Oncol. 11:7555782021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lv Y, Lin SY, Hu FF, Ye Z, Zhang Q, Wang Y
and Guo AY: Landscape of cancer diagnostic biomarkers from
specifically expressed genes. Brief Bioinform. 21:2175–2184. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tomczak K, Czerwinska P and Wiznerowicz M:
The cancer genome atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19:A68–A77. 2015.PubMed/NCBI
|
|
25
|
Fiorini N, Lipman DJ and Lu Z: Towards
PubMed 2.0. Elife. 6:e288012017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Akaike H: A new look at the statistical
model identification. IEEE Trans Automat Contr AC. 19:716–723.
1974. View Article : Google Scholar
|
|
28
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC cancer staging manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Strutner J, Ramchandar N, Dubey S, Gamboa
M, Vanderpool MK, Mueller T, Wang W, Cannavino C, Tovar Padua L,
Malicki D and Pong A: Comparison of RT-PCR cycle threshold values
from respiratory specimens in symptomatic and asymptomatic children
with SARS-CoV-2 infection. Clin Infect Dis: ciab403. 2021.(Epub
ahead of print). View Article : Google Scholar
|
|
30
|
Chen Y, Lu B, Yang Q, Fearns C, Yates JR
III and Lee JD: Combined integrin phosphoproteomic analyses and
small interfering RNA-based functional screening identify key
regulators for cancer cell adhesion and migration. Cancer Res.
69:3713–3720. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Warnes G and Martins S: Real-time flow
cytometry for the kinetic analysis of oncosis. Cytometry A.
79:181–191. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
D'Arcy MS: Cell death: A review of the
major forms of apoptosis, necrosis and autophagy. Cell Biol Int.
43:582–592. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Luo D, Ni Q, Ji A, Gu W, Wu J and Jiang C:
Dehydroabietic acid derivative QC4 induces gastric cancer cell
death via oncosis and apoptosis. Biomed Res Int. 2016:25810612016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang W, Fang D, Li S, Bao X, Jiang L and
Sun X: Construction and validation of a novel ferroptosis-related
lncRNA signature to predict prognosis in colorectal cancer
patients. Front Genet. 12:7093292021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yu J, Mao W, Xu B and Chen M: Construction
and validation of an autophagy-related long noncoding RNA signature
for prognosis prediction in kidney renal clear cell carcinoma
patients. Cancer Med. 10:2359–2369. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ghafouri-Fard S and Taheri M: Long
non-coding RNA signature in gastric cancer. Exp Mol Pathol.
113:1043652020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu S, Cao Q, An G, Yan B and Lei L:
Identification of the 3-lncRNA signature as a prognostic biomarker
for colorectal cancer. Int J Mol Sci. 21:93592020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wei J, Ge X, Tang Y, Qian Y, Lu W, Jiang
K, Fang Y, Hwang M, Fu D, Xiao Q and Ding K: An autophagy-related
long noncoding RNA signature contributes to poor prognosis in
colorectal cancer. J Oncol. 2020:47289472020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tang R, Wu Z, Rong Z, Xu J, Wang W, Zhang
B, Yu X and Shi S: Ferroptosis-related lncRNA pairs to predict the
clinical outcome and molecular characteristics of pancreatic ductal
adenocarcinoma. Brief Bioinform. 23:bbab3882022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Keulers TG, Koch A, van Gisbergen MW,
Barbeau LMO, Zonneveld MI, de Jong MC, Savelkouls KGM, Wanders RG,
Bussink J, Melotte V and Rouschop KMA: ATG12 deficiency results in
intracellular glutamine depletion, abrogation of tumor hypoxia and
a favorable prognosis in cancer. Autophagy. 18:1898–1914. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Llambi F, Wang YM, Victor B, Yang M,
Schneider DM, Gingras S, Parsons MJ, Zheng JH, Brown SA, Pelletier
S, et al: BOK is a non-canonical BCL-2 family effector of apoptosis
regulated by ER-associated degradation. Cell. 165:421–433. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dai W, Mu L, Cui Y, Li Y, Chen P, Xie H
and Wang X: Long non-coding RNA CASC2 enhances berberine-induced
cytotoxicity in colorectal cancer cells by silencing BCL2. Mol Med
Rep. 20:995–1006. 2019.PubMed/NCBI
|
|
44
|
Mazzu YZ, Liao Y, Nandakumar S, Sjöström
M, Jehane LE, Ghale R, Govindarajan B, Gerke TA, Lee GM, Luo JH, et
al: Dynamic expression of SNAI2 in prostate cancer predicts tumor
progression and drug sensitivity. Mol Oncol. 16:2451–2469. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Findlay VJ, Wang C, Nogueira LM, Hurst K,
Quirk D, Ethier SP, Staveley O'Carroll KF, Watson DK and Camp ER:
SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity
through miR145 repression. Mol Cancer Ther. 13:2713–2726. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Du F, Li X, Feng W, Qiao C, Chen J, Jiang
M, Qiu Z, Qian M, Tian D, Nie Y, et al: SOX13 promotes colorectal
cancer metastasis by transactivating SNAI2 and c-MET. Oncogene.
39:3522–3540. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Funke L, Bracht T, Oeck S, Schork K,
Stepath M, Dreesmann S, Eisenacher M, Sitek B and Schramm A:
NTRK1/TrkA signaling in neuroblastoma cells induces nuclear
reorganization and intra-nuclear aggregation of lamin A/C. Cancers
(Basel). 13:52932021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Willis ND, Cox TR, Rahman-Casañs SF, Smits
K, Przyborski SA, van den Brandt P, van Engeland M, Weijenberg M,
Wilson RG, de Bruïne A and Hutchison CJ: Lamin A/C is a risk
biomarker in colorectal cancer. PLoS One. 3:e29882008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kim DY, Cheong HT, Ra CS, Kimura K and
Jung BD: Effect of 5-azacytidine (5-aza) on UCP2 expression in
human liver and colon cancer cells. Int J Med Sci. 18:2176–2186.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Aguilar E, Esteves P, Sancerni T, Lenoir
V, Aparicio T, Bouillaud F, Dentin R, Prip-Buus C, Ricquier D,
Pecqueur C, et al: UCP2 deficiency increases colon tumorigenesis by
promoting lipid synthesis and depleting NADPH for antioxidant
defenses. Cell Rep. 28:2306–2316.e5. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Qiao C, Wei L, Dai Q, Zhou Y, Yin Q, Li Z,
Xiao Y, Guo Q and Lu N: UCP2-related mitochondrial pathway
participates in oroxylin A-induced apoptosis in human colon cancer
cells. J Cell Physiol. 230:1054–1063. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kim G, Lim S and Kim KD: N-myc
downstream-regulated gene 2 (NDRG2) function as a positive
regulator of apoptosis: A new insight into NDRG2 as a tumor
suppressor. Cells. 10:26492021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Moreno E and Barquero-Calvo E: The role of
neutrophils in brucellosis. Microbiol Mol Biol Rev. 84:e00048–20.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Davidson WF, Haudenschild C, Kwon J and
Williams MS: T cell receptor ligation triggers novel nonapoptotic
cell death pathways that are Fas-independent or Fas-dependent. J
Immunol. 169:6218–6230. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Cho U, Kim B, Kim S, Han Y and Song YS:
Pro-inflammatory M1 macrophage enhances metastatic potential of
ovarian cancer cells through NF-κB activation. Mol Carcinog.
57:235–242. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang S, Zheng B, Zhao H, Li Y, Zhang X and
Wen J: Downregulation of lncRNA MIR181A2HG by high glucose impairs
vascular endothelial cell proliferation and migration through the
dysregulation of the miRNAs/AKT2 axis. Int J Mol Med. 47:352021.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wu Y, Zhang L, He S, Guan B, He A, Yang K,
Gong Y, Li X and Zhou L: Identification of immune-related LncRNA
for predicting prognosis and immunotherapeutic response in bladder
cancer. Aging (Albany NY). 12:23306–23325. 2020.PubMed/NCBI
|
|
58
|
Yang F, Zhang J, Li B, Zhao Z, Liu Y, Zhao
Z, Jing S and Wang G: Identification of potential lncRNAs and
miRNAs as diagnostic biomarkers for papillary thyroid carcinoma
based on machine learning. Int J Endocrinol. 2021:39844632021.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Xu Y, Chen J, Yang Z and Xu L:
Identification of RNA expression profiles in thyroid cancer to
construct a competing endogenous RNA (ceRNA) network of mRNAs, long
noncoding RNAs (lncRNAs), and microRNAs (miRNAs). Med Sci Monit.
25:1140–1154. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Vishnubalaji R and Alajez NM: Epigenetic
regulation of triple negative breast cancer (TNBC) by TGF-β
signaling. Sci Rep. 11:154102021. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ye Z, Zheng M, Zeng Y, Wei S, Wang Y, Lin
Z, Shu C, Xie Y, Zheng Q and Chen L: Bioinformatics analysis
reveals an association between cancer cell stemness, gene
mutations, and the immune microenvironment in stomach
adenocarcinoma. Front Genet. 11:5954772020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Liu Z, Liu L, Weng S, Guo C, Dang Q, Xu H,
Wang L, Lu T, Zhang Y, Sun Z and Han X: Machine learning-based
integration develops an immune-derived lncRNA signature for
improving outcomes in colorectal cancer. Nat Commun. 13:8162022.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Song W, Ren J, Yuan W, Xiang R, Ge Y and
Fu T: N6-methyladenosine-related lncRNA signature predicts the
overall survival of colorectal cancer patients. Genes (Basel).
12:13752021. View Article : Google Scholar : PubMed/NCBI
|
